Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GRI
#5094
GRI Bio, Inc. Common Stock
2.470
0
USD
+1.23%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.23%
Monthly Change
-6.08%
6 month change
-6.79%
Year Change
-6.79%
Previous Close
2.440
0
Open
2.470
0
Bid
Ask
Low
2.470
0
High
2.470
0
Volume
20
Markets
US Stock Market
Healthcare
GRI
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Cash from operating activities
-2 M
-1.74 M
-3.17 M
-2.31 M
-2.97 M
-10.19 M
Cash from investing activities
0
—
—
—
—
—
Cash from financing activities
2.28 M
-11 K
5.01 M
1.25 M
7.15 M
13.39 M
Free cash flow
-2 M
-1.74 M
-3.17 M
-2.31 M
-2.97 M
-10.19 M
News
GRI Bio reports $8.2 million cash position, extends runway into Q1 2027
Grainger reports 3.1% rental growth, high occupancy in trading update
Grainger begins construction on second BTR scheme in Guildford
Grainger begins construction on second Guildford rental scheme
GRI Bio stock soars after gene data shows IPF drug targets disease drivers
GRI Bio reports positive gene expression data for IPF drug candidate
Grainger and Places for London partner on 195-home London scheme
GRI Bio stock falls after announcing 1-for-28 reverse split
GRI Bio announces 1-for-28 reverse stock split to regain Nasdaq compliance
GRI Bio shareholders approve reverse stock split and report Nasdaq compliance
GRI Bio stock rises on positive Phase 2a immune data for IPF treatment
GRI Bio reports positive Phase 2a data for IPF treatment